Healthcare -
Biotechnology - NASDAQ - US
$ 85.3
-2.88 %
$ 10.6 B
Market Cap
-18.87
P/E
PCVX - STOCK-BASED COMPENSATION
Stock-based Compensation PCVX - Vaxcyte, Inc.
48.8 M
LAST VALUE
113.18%
2 YEAR CAGR
130.52%
5 YEAR CAGR
0.00%
10 YEAR CAGR